Risk of Gastrointestinal Bleeding with Rivaroxaban: A Comparative Study with Warfarin

Introduction. The risk of gastrointestinal (GI) bleeding with rivaroxaban has not been studied extensively. The aim of our study was to assess this risk in comparison to warfarin. Methods. We examined the medical records for patients who were started on rivaroxaban or warfarin from April 2011 to Apr...

Descripción completa

Detalles Bibliográficos
Autores principales: Sherid, Muhammed, Sulaiman, Samian, Samo, Salih, Husein, Husein, Tupper, Ruth, Spurr, Charles, Sifuentes, Humberto, Sridhar, Subbaramiah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4736815/
https://www.ncbi.nlm.nih.gov/pubmed/26880901
http://dx.doi.org/10.1155/2016/9589036

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4736815/
https://www.ncbi.nlm.nih.gov/pubmed/26880901
http://dx.doi.org/10.1155/2016/9589036

Ejemplares similares